Skip to main content
SpringerLink
Log in

Radiotherapy for Graves’ ophthalmopathy

  • Chapter
Recent Developments in Graves’ Ophthalmopathy

Abstract

The interest in the treatment of benign diseases with radiation therapy has grown particularly in the Western part of the world. In 1996, a questionnaire was sent to 1348 institutes worldwide listed in the directory of the Society for Therapeutic Radiology and Oncology asking whether the respondents considered a list of 28 most common benign disorders as being a good indication for orbital radiotherapy.1 Questions concerned the frequency of such treatments and the treatment schedules used. The prevention of keloid formation was the most widely accepted indication, followed by Graves’ ophthalmopathy. Thus, radiotherapy for this orbital disorder is generally accepted and applied worldwide.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Leer JWH, van Houtte P, Davelaar J. Indications and treatment schedules for irradiation of benign diseases: a survey. Radiother Oncol 1998; 48: 249–257

    Article  PubMed  CAS  Google Scholar 

  2. Juler FA. Acute purulent keratitis in exophthalmic goiter treated by repeated tarsorrhaphy resection of cervical sympathetis and x-rays: retention of vision in one eye. Trans Ophthalmol Soc UK 1913; 33: 58–62

    Google Scholar 

  3. Mandeville FB. Roetgen therapy of orbital-pituitary portals for progressive exophthalmos following subtotal thyroidectomy. Radiology 1943; 41: 268–271

    Google Scholar 

  4. Jones A. Orbital x-ray therapy of progressive exophthalmos. Br J Radiol 1951; 24: 637–646

    Article  PubMed  CAS  Google Scholar 

  5. Beierwaltes WH. X-ray treatment of malignant exophthalmos: a report of 28 patients. J Clin Endocrinol 1953; 13: 1090–1100

    Article  CAS  Google Scholar 

  6. Bahn RS, Heufelder AE. Pathogenesis of Graves’ophthalmopathy. N Engl J Med 1993; 329: 1468–1475

    Article  PubMed  CAS  Google Scholar 

  7. Burch HB, Wartofsky L. Graves’ophthalmopathy: current concepts regarding pathogenesis and management. Endocrin Rev 1993; 14: 747–93

    CAS  Google Scholar 

  8. Kahaly G, Hansen C, Felke B, Dienes HP. Immunohistochemical staining of retrobulbar adipose tissue in Graves’ophthalmopathy. Clin Immunol Immunopathol 1994; 73: 53–62

    Article  PubMed  CAS  Google Scholar 

  9. Otto E, Ochs K, Hansen C, Wall J, Kahaly G. Orbital tissue-derived T lymphocytes from patients with Graves’ophthalmopathy recognize autologous orbital antigens. J Clin Endocrinol Metab 1996; 81: 3045–3050

    Article  PubMed  CAS  Google Scholar 

  10. Förster G, Otto E, Hansen C, Ochs K, Kahaly GJ. Analysis of orbital T cells in Thyroid-Associated Opthalmopathy. Clin Exp Immunol 1998; 112: 427–434

    Article  PubMed  Google Scholar 

  11. Hansen C, Fraiture B, Rouhi R, Otto E, Förster G, Kahaly G. HPLC glycosaminoglycan analysis in patients with Graves’disease. Clin Science 1997; 92: 511–517

    CAS  Google Scholar 

  12. Hansen C, Rouhi R, Förster G, Kahaly GJ. Increased Sulfatation of Orbital Glycosaminoglycans in Graves’Ophthalmopathy. J Clin Endocrinol Metab 1999; 84:1409–1413.

    Article  PubMed  CAS  Google Scholar 

  13. DeGroot LJ, Gorman CA, Pinchera A. et al. Radiation and Graves’ophthalmopathy. Therapeutic controversies. J Clin Endocrinol Metab 1995; 80: 339–349

    Article  CAS  Google Scholar 

  14. Bartalena L, Marcocci C, Manetti L. et al. Orbital radiotherapy for Graves’ophthalmopathy. Thyroid 1998; 8: 439–441

    Article  PubMed  CAS  Google Scholar 

  15. Marcocci C, Bartalena L, Bruno-Bossio G. et al. Orbital radiotherapy in the treatment of endocrine ophthalmopathy: Why and when? In: Kahaly G (ed) Endocrine Ophthalmopathy — Molecular, immunological and clinical aspects. Karger, Basel, 1993: 131–141

    Google Scholar 

  16. Sautter-Bihl M-L. Orbital radiotherapy: recent experience in Europe. In: Wall JR, How J, eds. Graves’ophthalmopathy. Cambridge: Blackwell 1990; 145–157

    Google Scholar 

  17. Wiersinga WM, Smit T, Schuster-Uittenhoeve ALJ, van der Gaag, Koornneef L. Therapeutic outcome of prednisone medication and of orbital irradiation in patients with Graves’ophthalmopathy. Ophthalmologica 1988; 197: 75–84

    Article  PubMed  CAS  Google Scholar 

  18. Olivotto IA, Ludgate CM, Allen LH, Rootman J. Supervoltage radiotherapy for Graves’ophthalmopathy. CCABC technique and results. Int J Radiation Oncol Biol Phys 1985; 11: 2085–2090

    Article  CAS  Google Scholar 

  19. Sandler HM, Rubenstein JH, Fowble BL, Sergott RC, Savino PJ, Bosley TM. Results of radiotherapy for thyroid ophthalmopathy. Int J Radiat Oncol Biol Phys 1989; 17: 823–827

    Article  PubMed  CAS  Google Scholar 

  20. Kao SCS, Kendler DL, Nugent RA, Adler JS, Rootman J. Radiotherapy in the management of thyroid orbitopathy. Arch Ophthalmol 1993; 111: 819–823

    Article  PubMed  CAS  Google Scholar 

  21. Nakahara H, Noguchi S, Murakami N. et al. Graves’ophthalmopathy: MR evaluation of 10-Gy versus 24-Gy irradiation combined with systemic corticosteroids. Radiology 1995; 196: 857–862

    PubMed  CAS  Google Scholar 

  22. Prummel MF, Wiersinga WM, Mourits MP, Koorneef L, Berghout A, vd Gaag R. Influence of abnormal thyroid function on the severity of accompanying Graves’ophthalmopathy. Arch Int Med 1990; 150: 1098–1101

    Article  CAS  Google Scholar 

  23. Erickson BA, Harris GJ, Lewandowski MF, Murray KJ, Massaro BM. Echographic monitoring of response of extraocular muscles to irradiation in Graves’ophthalmopathy. Int J Radiat Oncol Biol Phys 1995; 31: 651–660

    Article  PubMed  CAS  Google Scholar 

  24. Prummel MF, Mounts MP, Blank L, Berghout A, Koorneef L, Wiersinga WM. Randomised double-blind trial of prednisone versus radiotherapy in Graves’ophthalmopathy. Lancet 1993; 342: 949–954

    Article  PubMed  CAS  Google Scholar 

  25. Mourits MP. Randomized double blind trial of orbital radiotherapy vs sham irradiation in Graves’ophthalmopathy. VIth International Symposium on Graves’ophthalmopathy, Amsterdam, NL, Nov. 27–28, 1998

    Google Scholar 

  26. Gorman CA. Orbital radiotherapy for Graves’opthalmopathy: a randomized, double blind, prospective, clinical trial. VIth International Symposium on Graves’ophthalmopathy, Amsterdam, NL, Nov. 27–28, 1998

    Google Scholar 

  27. Hildebrandt G, Seed MP, Freemantle CN, Alam CAS, Colville-Nash PR, Trott KR. Mechanisms of the anti-inflammatory activity of low-dose radiation therapy. Int J Radiat Biol 1998; 74:367–378

    Article  PubMed  CAS  Google Scholar 

  28. Kahaly GJ. Low vs high dose radiotherapy for Graves’opthalmopathy. VIth International Symposium on Graves’ophthalmopathy, Amsterdam, NL, Nov. 27–28, 1998

    Google Scholar 

  29. Ravin JG, Sisson JC, Knapp WT. Orbital radiation for the ocular changes of Graves’disease. Am J Ophthalmol 1975; 79: 285–288

    PubMed  CAS  Google Scholar 

  30. Trott KR. Therapeutic effects of low radiation doses. Strahlenther Onkologie 1994; 170: 1–12

    CAS  Google Scholar 

  31. McCartney-Francis N, Allen JB, Mizel DE. et al. Suppression of arthritis by an inhibitor of nitric oxide synthase. J Exp Med 1993; 178: 749–754

    Article  PubMed  CAS  Google Scholar 

  32. Hofbauer LC, Mühlberg T, Konig A, Heufelder G, Schworn HD, Heufelder AE. Soluble Interleukin-1 receptor antagonist serum levels in smokers and nonsmokers with Graves’ophthalmopathy undergoing orbital radiotherapy. J Clin Endocrinol Metab 1997; 82: 2244–2247

    Article  PubMed  CAS  Google Scholar 

  33. Bartalena L, Marcocci C, Tanda ML. et al. Cigarette smoking and Graves’ophthalmopathy. Ann Intern Med 1998; 129: 632–635.

    PubMed  CAS  Google Scholar 

  34. Tan HS. Orbital radiotherapy in Graves’ophthalmopathy: is it safe? VIth International Symposium on Graves’ophthalmopathy, Amsterdam, NL, Nov. 27–28, 1998

    Google Scholar 

  35. Kriss JP, Petersen IA, Donaldson SS, McDougall IR. Supervoltage orbital radiotherapy for progressive Graves’opthalmopathy: results of a twenty year experience. Acta Endocrinol 1989; 121:154–159

    Google Scholar 

  36. Petersen IA, Kriss JP, McDougall IR, Donaldson SS. Prognostic factors in the radiotherapy of Graves’ophthalmopathy. Int J Radiat Oncol Biol Phys 1990; 19: 259–264

    Article  PubMed  CAS  Google Scholar 

  37. Miller ML, Goldberg SH, Bullock JD. Radiation retinopathy after standard radiotherapy for thyroid-related ophthalmopathy. Am J Ophthalmol 1991; 112: 600–601

    PubMed  CAS  Google Scholar 

  38. Kinyoun JL, Kalina RE, Brower SA, Mills RP, Johnson RH. Radiation retinopathy after orbital irradiation for Graves’ophthalmopathy. Arch Ophthalmol 1984; 102: 1473–1476

    Article  PubMed  CAS  Google Scholar 

  39. Parker RG, Withers HR. Radiation retinopathy. JAMA 1988; 259: 43

    Article  PubMed  CAS  Google Scholar 

  40. Viebahn M, Marricks ME, Osterloh MD. Synergism between diabetic and radiation retinopathy: case report and review. Br J Ophthalmol 1991; 75: 29–32

    Article  Google Scholar 

  41. Nikoskelainen E, Joensuu H. Retinopathy after irradiation for Graves’ophthalmopathy. Lancet 1989; 2: 690

    Article  PubMed  CAS  Google Scholar 

  42. Nygaard B, Specht L. Transitory blindness after retrobulbar irradiation of Graves’ophthalmopathy. Lancet 1998; 351: 725–726

    Article  PubMed  CAS  Google Scholar 

  43. Elsas T, Thorud E, Jetne V, Conradi IS. Retinopathy after low dose irradiation for an intracranial tumor of the frontal lobe. Acta Ophthalmol 1988; 66: 65–68

    CAS  Google Scholar 

  44. Lopez PF, Sternberg P, Dabbs CK, Volgler WR, Crocker I, Kalin NS. Bone marrow transplant retinopathy. Am J Ophthalmol 1991; 112: 635–646

    PubMed  CAS  Google Scholar 

  45. Broerse JJ. Calculation of effective dose for irradiation of Graves’ophthalmopathy. VIth International Symposium on Graves’ophthalmopathy, Amsterdam, NL, Nov. 27–28, 1998

    Google Scholar 

  46. Snijders-Keilholz A, De Keizer RJ, Goslings BM, Van Dam EWCM, Jansen JThM, Broerse JJ. Probable risk of tumour induction after retroorbital irradiation for Graves’ophthalmopathy. Radiother Oncol 1996; 38: 69–71

    Article  PubMed  CAS  Google Scholar 

  47. Van Leeuwen FE, Klokman WJ, Hagenbeek A. et al. Second cancer risk following Hodgkin’s disease: a 20-year follow-up study. J Clin Oncol 1994; 12: 312–325

    PubMed  Google Scholar 

  48. Blank LECM, Barendsen GW, Prummel MF, Stalpers L, Wiersinga W, Koornneef L. Probable risk of tumor induction after retroorbital irradiation for Graves’ophthalmopathy. Radiother Oncol 1996; 40: 187–188

    Article  PubMed  CAS  Google Scholar 

  49. Kal HB. Orbital radiotherapy in Graves’ophthalmopathy: is it effective? VIth International Symposium on Graves’ophthalmopathy, Amsterdam, NL, Nov. 27–28, 1998

    Google Scholar 

  50. Hendry JH. Biological response modifiers and normal tissue injury after irradiation. Radiat Oncol 1994; 4: 123–132

    Google Scholar 

  51. Woloschak GE, Chang-Liu CM. Differential modulation of specific gene expression following high-and low radiations. Radiat Res 1990; 124: 183–187

    Article  PubMed  CAS  Google Scholar 

  52. Rodemann HP, Peterson HP, Schwenke K, von Wangenheim KH. Terminal differentiation of human fibroblasts is induced by radiation. Scan Microsc 1992; 5: 1135–1143

    Google Scholar 

  53. Rodemann HP, Bamberg M. Cellular basis of radiation-induced fibrosis. Radiother Oncol 1995; 35:83–90

    Article  PubMed  CAS  Google Scholar 

  54. Remy J, Wegrowski J, Crechet F, Martin M, Daburon F. Longterm overproduction of collagen in radiation-induced fibrosis. Radiat Res 1991; 125: 14–19

    Article  PubMed  CAS  Google Scholar 

  55. Canney PA, Dean St. Transforming growth factor beta. A promoter of late connective tissue injury following radiotherapy? Br J Radiol 1990; 63: 620–623

    Article  PubMed  CAS  Google Scholar 

  56. Martin M, Lefaix JL, Pinton P, Crechet F, Daburon F. Temporal modulation of TGF-ß1 and ß-actin gene expression in pig skin and muscular fibrosis after ionizing radiation. Radiat Res 1993; 134: 63–70

    Article  PubMed  CAS  Google Scholar 

  57. Haimovitzfriedemann A, Vlodavsky I, Chaudhuri A, Witte L, Fuks Z. Autocrine effects of fibroblast growth factor in repair of radiation damage in endothelial cells. Cancer Res 1991;51:2552–2558

    Google Scholar 

  58. Strieter RM, Wiggings R, Phan SH. et al. Monocyte chemotactic protein gene expression by cytokine-treated human fibroblasts and the epithelial cells. Biochem Biophys Res Commun 1989; 162: 694–700

    Article  PubMed  CAS  Google Scholar 

  59. Langberg CW, Hauer-Jensen M, Sung SS, Kane C. Expression of fibrogenic cytokines in rat small intestine after fractionated irradiation. Radiother Oncol 1994; 32: 29–36

    Article  PubMed  CAS  Google Scholar 

  60. Mühlberg T, Spitzweg C, Heberling HJ, Heufelder AE. Regulation of Interleukin-1 receptor antagonist gene and protein variants by radiotherapy in Graves’ retroocular fibroblasts. J Endocrinol Invest 1998; 21(Suppl to no. 4): 67 (Abstract)

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Endocrinology/Metabolism, University of Mainz, Building 303, Johannes Gutenberg Klinikum, 55101, Mainz, Germany

    George J. Kahaly

Authors
  1. George J. Kahaly
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Colum A. Gorman
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Henk B. Kal
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maarten Ph. Mourits
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Aldo Pinchera
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. H. Stevie Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mark F. Prummel
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Endocrinology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands

    Mark F. Prummel M.D. Ph.D.  & Wilmar M. Wiersinga M.D. Ph.D. (Professor of Endocrinology) &  (Professor of Endocrinology)

  2. Department of Ophthalmology, Orbital Center, University Medical Center Utrecht, Heidelberglaan 100, The Netherlands

    Maarten Ph. Mourits M.D. Ph.D.

  3. Zentrum für Innere Medizin mit Schwerpunkt Gastroenterologie, Endokrinologie, Diabetologie, Klinikum der Philipps-Universität Marburg, Baklingerstrasse, 35033, Marburg, Germany

    Armin E. Heufelder M.D. Ph.D. (Professor of Endocrinology) (Professor of Endocrinology)

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer Science+Business Media New York

About this chapter

Cite this chapter

Kahaly, G.J. et al. (2000). Radiotherapy for Graves’ ophthalmopathy. In: Prummel, M.F., Wiersinga, W.M., Mourits, M.P., Heufelder, A.E. (eds) Recent Developments in Graves’ Ophthalmopathy. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4647-4_8

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4647-4_8

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7102-1

  • Online ISBN: 978-1-4615-4647-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation